Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Two strengths of sertraline among initial October price concessions

The Department of Health and Social Care and the National Assembly for Wales have agreed on concessionary prices for the following 18 items for October 2020 prescriptions.

Drug
Strength
Form
Price
Duloxetine
20mg
gastro-resistant capsules (28)
£7.99
Duloxetine
60mg
gastro-resistant capsules (28)
£4.10
Enalapril
10mg
tablets (28)
£5.49
Enalapril
20mg
tablets (28)
£10.00
Estradiol
1mg
tablets (84)
£6.89
Estradiol
2mg
tablets (84)
£6.89
Hydroxyzine
10mg
tablets (84)
£1.77
Moxonidine
200microgram
tablets (28)
£9.46
Moxonidine
300microgram
tablets (28)
£10.99
Moxonidine
400microgram
tablets (28)
£12.07
Naftidrofuryl
100mg
capsules (84)
£7.25
Olanzapine
15mg
tablets (28)
£3.95
Olanzapine
20mg
tablets (28)
£5.10
Oxytetracycline
250mg
tablets (28)
£9.10
Senna
7.5mg
tablets (60)
£2.76
Sertraline
100mg
tablets (28)
£6.72
Sertraline
50mg
tablets (28)
£4.74
Valsartan
160mg
capsules (28)
£12.01

Do these prices reflect what you have paid so far this month?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD006784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel